Related Experiment Video
Updated: Oct 12, 2025

04:38
A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
Published on: May 22, 2019
10.5K
Preventive Approaches for Post-Stroke Depression: Where Do We Stand? A Systematic Review
Warunya Woranush1,2, Mats Leif Moskopp2,3, Annahita Sedghi1
1Department of Neurology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Neuropsychiatric Disease and Treatment
|November 26, 2021
Summary
Preventing post-stroke depression (PSD) is crucial for recovery. Antidepressants show strong evidence, while psychotherapy is common; combined approaches may offer the best strategy for stroke survivors.
Area of Science:
- Neurology
- Psychiatry
- Public Health
Background:
- Post-stroke depression (PSD) affects one-third of survivors, impairing recovery and quality of life.
- Early detection and prevention of PSD are vital to mitigate its impact.
- Current evidence on PSD prevention strategies needs systematic review.
Purpose of the Study:
- To systematically review current evidence on pharmacological and non-pharmacological methods for preventing post-stroke depression.
- To identify effective interventions for reducing the incidence of PSD in stroke survivors.
Main Methods:
- Systematic review of randomized controlled studies using PubMed/MEDLINE and bibliographies.
- Inclusion criteria: studies within 1 year of stroke, excluding animal research, reviews, and case reports.
- PRISMA guidelines were followed for study selection and data extraction.
Main Results:
- 37 studies met the criteria from 150 screened.
- Antidepressants demonstrated robust evidence for PSD prevention.
- Non-pharmacological interventions, like psychotherapy, are frequently used; efficacy increases with treatment duration.
- Pharmacological interventions were effective in 63% of studies, non-pharmacological in 50%.
Conclusions:
- Literature on PSD prevention is heterogeneous, highlighting the need for rigorous RCTs.
- Combined pharmacological (e.g., SSRIs) and non-pharmacological strategies (educational, mental, physical support) show promise.
- Personalized, integrative approaches are recommended to minimize PSD risk in stroke survivors.

